Brivaracetam

Jump to: navigation, search
Brivaracetam
IUPAC name (2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide
Properties
Molecular formula C11H20N2O2
Molar mass 212.29 g mol-1
Pharmacology
Routes of
administration
Oral
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)

Infobox disclaimer and references


Brivaracetam is a racetam derivative with anticonvulsant properties.

See also


Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox